RankingsPricing
  1. US-listed companies
  2. CONMED Corp
  3. Financials
  4. Research & development

CONMED CorpCNMD

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 202454+3.47%
Dec 31, 202353+11.56%
Dec 31, 202247+8.23%
Dec 31, 202144+7.64%
Dec 31, 202040-10.97%
Dec 31, 201945+7.76%
Dec 31, 201842+30.58%
Dec 31, 201732+0.16%
Dec 31, 201632+17.56%
Dec 31, 201527-1.23%
Dec 31, 201428+7.54%
Dec 31, 201326-8.45%
Dec 31, 201228-1.53%
Dec 31, 201129

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)